T
Texas Institute for Kidney and Endocrine Disorders | Lufkin, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BI 685509
LY3298176
Canagliflozin
LY900014
Evolocumab
Tirzepatide
Retatrutide
Empagliflozin
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
Locations recently updated
This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...
Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide
This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...
Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo
Locations recently updated
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...
Enrolling
Overweight and Obesity
Drug: Retatrutide
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems